Abstract
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in the regulation of gene expression. Their involvement in various cellular processes such as cell differentiation, proliferation, apoptosis, and metabolism has made them a subject of intense research in drug discovery and development. miRNAs have been shown to be key regulators in numerous diseases, including cancer, cardiovascular diseases, and neurological disorders. This article explores the potential of miRNAs as therapeutic targets and biomarkers in drug development. The role of miRNA-based therapies, their delivery methods, and their challenges in clinical applications are also discussed. By targeting specific miRNAs, drug developers can design more precise and effective treatments for complex diseases.
References
Ahmad, N. R. (2025). Rebuilding public trust through state-owned enterprise reform: A transparency and accountability framework for Pakistan. Punjab Sahulat Bazaars Authority. https://doi.org/10.52152/6q2p9250
Ahmad, N. R. (2025). Human–AI collaboration in knowledge work: Productivity, errors, and ethical risk. https://doi.org/10.52152/6q2p9250

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Dr. Asma Khan (Author)